HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaofei Wang Selected Research

hydrazinocurcumin

1/2013Hydrazinocurcumin Encapsuled nanoparticles "re-educate" tumor-associated macrophages and exhibit anti-tumor effects on breast cancer following STAT3 suppression.
4/2012The curcumin analogue hydrazinocurcumin exhibits potent suppressive activity on carcinogenicity of breast cancer cells via STAT3 inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaofei Wang Research Topics

Disease

141Neoplasms (Cancer)
12/2022 - 09/2004
48Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2022 - 12/2006
28Neoplasm Metastasis (Metastasis)
01/2022 - 03/2010
23Stomach Neoplasms (Stomach Cancer)
01/2022 - 07/2015
20Leukemia
10/2019 - 01/2007
16Lung Neoplasms (Lung Cancer)
06/2022 - 02/2008
16Hepatocellular Carcinoma (Hepatoma)
01/2022 - 11/2012
14Carcinogenesis
01/2022 - 08/2010
13Carcinoma (Carcinomatosis)
03/2022 - 06/2005
13Inflammation (Inflammations)
01/2022 - 11/2007
10Breast Neoplasms (Breast Cancer)
04/2021 - 05/2010
9Thyroid Neoplasms (Thyroid Cancer)
02/2022 - 04/2016
9Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 01/2014
9Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2021 - 02/2008
9Infections
01/2021 - 07/2007
8Disease Progression
06/2022 - 10/2019
8Hypoxia (Hypoxemia)
09/2021 - 09/2004
8Atherosclerosis
11/2020 - 06/2002
7Intervertebral Disc Degeneration
07/2021 - 06/2016
7Adenocarcinoma
07/2021 - 12/2006
7Rheumatoid Arthritis
01/2021 - 10/2004
6Sarcoma (Soft Tissue Sarcoma)
03/2022 - 01/2021
6Obesity
01/2022 - 02/2004
6Necrosis
01/2022 - 04/2005
6Spinal Cord Injuries (Spinal Cord Injury)
02/2015 - 05/2007
5Reperfusion Injury
01/2021 - 10/2005
5Insulin Resistance
11/2020 - 02/2004
5Stroke (Strokes)
01/2019 - 02/2005
5Pancreatic Neoplasms (Pancreatic Cancer)
01/2019 - 12/2006
4Pain (Aches)
01/2022 - 03/2005
4Acute Lung Injury
10/2021 - 12/2013
4Fatigue
09/2021 - 09/2011
4Hypertension (High Blood Pressure)
08/2021 - 06/2012
4Head and Neck Neoplasms (Head and Neck Cancer)
03/2021 - 01/2020
4Autoimmune Diseases (Autoimmune Disease)
01/2021 - 02/2010
4Neutropenia
01/2021 - 06/2012
4Liver Neoplasms (Liver Cancer)
01/2021 - 02/2011
4Malignant Mesothelioma
11/2020 - 10/2010
4Fibrosis (Cirrhosis)
06/2020 - 01/2011
4Wounds and Injuries (Trauma)
01/2020 - 01/2014
4Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 11/2016
4Ischemia
10/2019 - 04/2005
4Melanoma (Melanoma, Malignant)
06/2019 - 08/2010

Drug/Important Bio-Agent (IBA)

40Proteins (Proteins, Gene)FDA Link
12/2022 - 12/2006
25Biomarkers (Surrogate Marker)IBA
12/2022 - 06/2010
21Biological ProductsIBA
01/2022 - 09/2004
19MicroRNAs (MicroRNA)IBA
01/2021 - 06/2014
14Messenger RNA (mRNA)IBA
01/2022 - 03/2010
13Carboplatin (JM8)FDA LinkGeneric
08/2021 - 01/2007
13Pharmaceutical PreparationsIBA
01/2021 - 03/2005
10Paclitaxel (Taxol)FDA LinkGeneric
08/2021 - 01/2007
10Matrix Metalloproteinases (MMPs)IBA
01/2020 - 10/2004
9CytokinesIBA
12/2022 - 11/2007
9ErbB Receptors (EGF Receptor)IBA
07/2021 - 12/2006
8RNA (Ribonucleic Acid)IBA
01/2022 - 01/2016
8LigandsIBA
09/2021 - 06/2014
8PlatinumIBA
11/2020 - 07/2013
7Cadherins (E-Cadherin)IBA
10/2021 - 03/2015
7Small Interfering RNA (siRNA)IBA
04/2021 - 08/2010
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 12/2006
7Estrogens (Estrogen)FDA Link
01/2009 - 05/2003
6Tyrosine Kinase InhibitorsIBA
01/2022 - 09/2004
6CateninsIBA
01/2022 - 01/2017
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2021 - 09/2004
6Transforming Growth Factors (Transforming Growth Factor)IBA
01/2021 - 03/2010
6Glucose (Dextrose)FDA LinkGeneric
11/2020 - 02/2004
6Peptides (Polypeptides)IBA
06/2020 - 01/2015
5Immune Checkpoint InhibitorsIBA
12/2022 - 06/2019
5lenvatinibIBA
01/2022 - 03/2020
5EnzymesIBA
09/2021 - 01/2014
5Eosine Yellowish-(YS) (Eosin)IBA
07/2021 - 04/2013
5Hematoxylin (Haematoxylon)IBA
07/2021 - 04/2013
5Hormones (Hormone)IBA
01/2021 - 02/2005
5LipidsIBA
11/2020 - 02/2004
5Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2019 - 06/2012
5Celecoxib (Celebrex)FDA Link
10/2019 - 12/2006
5Nylons (Nylon)IBA
04/2015 - 03/2010
4AlbuminsIBA
05/2022 - 01/2018
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 06/2005
4eribulinFDA Link
12/2021 - 01/2021
4LipopolysaccharidesIBA
10/2021 - 11/2013
4Interleukin-6 (Interleukin 6)IBA
10/2021 - 03/2008
4Etoposide (VP 16)FDA LinkGeneric
01/2021 - 02/2008
4Dextran SulfateIBA
01/2021 - 10/2018
4CholesterolIBA
12/2020 - 02/2004
4Histones (Histone)IBA
11/2020 - 09/2004
4Pemetrexed (MTA)FDA Link
11/2020 - 08/2011
4MicellesIBA
01/2020 - 01/2016
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2019 - 02/2008
4Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
10/2019 - 12/2006

Therapy/Procedure

49Therapeutics
12/2022 - 02/2004
40Drug Therapy (Chemotherapy)
01/2022 - 01/2007
22Radiotherapy
01/2022 - 12/2006
6Immunotherapy
04/2022 - 01/2020
6Neoadjuvant Therapy
04/2022 - 12/2006
6Radiofrequency Ablation
10/2021 - 07/2017
6Chemoradiotherapy
01/2021 - 05/2010
6Induction Chemotherapy
09/2017 - 05/2008
5Adjuvant Chemotherapy
04/2016 - 05/2010
4Thyroidectomy
01/2022 - 04/2016